Moneycontrol
Last Updated : Mar 26, 2018 02:25 PM IST | Source: CNBC-TV18

Have strong order book; life science business stands at USD 151m, says Take Solutions

In an interview to CNBC-TV18, Srinivasan HR, VC & MD of Take Solutions spoke about the latest happenings in the company and gave his outlook for the future.

CNBC TV18 @moneycontrolcom

The Take Solutions stock has not had a great start to 2018, but a recent brokerage note suggests investors are upbeat about the prospects of the company capturing a bigger share of life sciences drug discovery spending.

In an interview to CNBC-TV18, Srinivasan HR, VC & MD of Take Solutions spoke about the latest happenings in the company and gave his outlook for the future.

Srinivasan said that life sciences research and development (R&D) services business is a large market of about USD 35-40 billion.

He further said that for the first nine months of the year we have grown our life science business at 30 percent in dollar terms and in rupee terms it’s about 25 percent.

We have a healthy order book and life science business alone stands at USD 151 million and we expect this growth trend to continue over the next several quarters, he added.

For entire interview, watch accompanying video.
First Published on Mar 26, 2018 02:05 pm

tags #Business

Sections
Follow us on
Available On